tiprankstipranks
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
US Market
GALT
Galectin Therapeutics
RESEARCH TOOLSreports

Galectin Therapeutics (GALT) Financial Statements

668 Followers

Galectin Therapeutics Financial Overview

Galectin Therapeutics's market cap is currently $154.69M. The company's EPS TTM is $-0.08; its P/E ratio is -8.62; Galectin Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -37.00K$ -33.00K$ -32.00K$ -41.00K
Operating Income$ -20.09M$ -42.43M$ -38.07M$ -38.35M$ -30.18M
EBITDA$ -23.45M$ -41.47M$ -38.24M$ -37.71M$ -30.00M
Net Income$ -30.84M$ -47.05M$ -41.07M$ -38.78M$ -30.53M
Balance Sheet
Cash & Short-Term Investments$ 17.72M$ 15.12M$ 25.66M$ 18.59M$ 39.65M
Total Assets$ 19.53M$ 17.50M$ 28.20M$ 21.29M$ 41.83M
Total Debt$ 133.74M$ 106.25M$ 71.81M$ 39.87M$ 29.06M
Net Debt$ 116.02M$ 91.13M$ 46.15M$ 21.28M$ -10.59M
Total Liabilities$ 145.73M$ 120.56M$ 88.44M$ 53.48M$ 39.21M
Stockholders' Equity$ -126.19M$ -103.07M$ -60.24M$ -32.19M$ 2.62M
Cash Flow
Free Cash Flow$ -23.88M$ -41.77M$ -32.97M$ -31.06M$ -24.31M
Operating Cash Flow$ -23.88M$ -41.77M$ -32.97M$ -31.06M$ -24.31M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 26.48M$ 31.23M$ 40.03M$ 10.00M$ 36.81M
Currency in USD

Galectin Therapeutics Earnings and Revenue History

Income Statement >

Galectin Therapeutics Debt to Assets

Balance Sheet >

Galectin Therapeutics Cash Flow

Cash Flow >

Galectin Therapeutics Forecast EPS vs Actual EPS

Earnings >